Tirzepatide
The dual GIP/GLP-1 agonist behind Mounjaro and Zepbound, studied heavily in weight and metabolic research.
Get told when a price moves or a lab test changes.
Observed median price
$341
Every observation
| Date | Observed |
|---|---|
| $110.00 | |
| $240.38 | |
| $240.38 | |
| $240.38 | |
| $240.38 | |
| $240.38 | |
| $240.38 | |
| $240.38 | |
| $240.38 | |
| $240.38 | |
| $240.38 | |
| $110.00 | |
| $240.38 | |
| $240.38 | |
| $240.38 | |
| $240.38 | |
| $240.38 | |
| $240.38 | |
| $240.38 | |
| $240.38 | |
| $110.00 | |
| $110.00 | |
| $110.00 | |
| $110.00 | |
| $110.00 | |
| $110.00 | |
| $110.00 | |
| $110.00 | |
| $110.00 | |
| $110.00 | |
| $110.00 | |
| $110.00 | |
| $110.00 | |
| $110.00 | |
| $110.00 | |
| $110.00 |
Not enough listings with 30 days of checks to summarise a change — 1 of 6 qualify so far.
6
Active listings
58 · 99.8%
Independent lab tests
$61–$573
Observed price range
4
Known aliases
Read from the certificate, not re-measured by VialGrade. Purity is not a grade. Purity vs grade
Understand this compound
What is Tirzepatide?
FDA-approved moleculea.k.a. Mounjaro, ZepboundThe molecule behind Mounjaro and Zepbound. It mimics two gut fullness hormones at once, which is why its weight-loss trial numbers beat the single-hormone drugs.
Good to know: GI adverse events are the most common trial finding, and the source/purity of non-prescription 'research' tirzepatide is unverified.
How does Tirzepatide work?
The science
A dual GIP/GLP-1 receptor agonist; activates both incretin receptors to enhance glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite.
Mechanism of action from published research — how the molecule behaves, not a claim about any product or any human-use effect.
What is Tirzepatide researched for?
Studied for type-2 diabetes glycemic control and obesity/weight management, plus obstructive sleep apnea and other metabolic conditions.
- Weight & metabolicStudied in weight, appetite, blood-sugar, and fat-metabolism research.
How far has the research gone?
FDA-approved (for type-2 diabetes and obesity); approved as Mounjaro (2022) and Zepbound (2023), including a 2024 sleep apnea indication.
Where the science stands — an approved drug is not the same as the research-grade material a vendor sells, which is unregulated regardless.
What should I check before buying?
- Independent purity. Look for a third-party COA (Janoshik or MZ) showing a measured purity — not just a number the vendor typed.
- Batch match. The strongest evidence is a certificate for the exact batch you’ll receive, attributed to this vendor — check the cross-verification on the listing.
- Vendor reputation. See how the vendor is talked about in the community before trusting a new name.
Research context only — VialGrade never gives dosing, medical, or human-use guidance.
Current market
The Tirzepatide market
Every Tirzepatide listing we track — 6 in all. The standout picks first where the evidence supports them, then the full table, ranked by what a milligram really costs wherever the vendor published a strength we can read.
Open full marketTirzepatide Peptide · 10mg
PureRawzC-
$123$12.3/mg
Lowest price per mg that isn't flagged as suspiciously cheap.
UnavailableChecked 15 days ago
Tirzepatide 5mg
Nootropic SourceC-
$110$22.0/mg
The most recently re-verified listing on this market.
In stockChecked 7 hours ago
Tirzepatide Sublingual Tablets · 350mcg per tablet/30ct/10.5mg
PureRawzC-
$390$37.1/mg
Ranked #3 of 3 listings by price per milligram.
UnavailableChecked 15 days ago
Compare by real cost
Every Tirzepatide listing, cheapest per mg first
Sticker prices hide the size, so listings are ranked by what a milligram actually costs — with independently tested purity where it exists. All 6 are here: the last 3 are listings whose vendor never published a strength we can read, so they have no per-mg figure to sort on.
| # | Vendor | Size | Price | Per mg | Tested purity | Real $/active mg | |
|---|---|---|---|---|---|---|---|
| 1 | PurerawzUnavailable | 10mg total | $123 | $12.3/mg | — | $12.3/mgbest value | View |
| 2 | Nootropic Source | 5mg total | $110 | $22.0/mg | — | $22.0/mg | View |
| 3 | PurerawzUnavailable | 10.5mg totalSublingual Tablets · 350mcg per tablet/30ct/10.5mg each | $390 | $37.1/mg | — | $37.2/mg | View |
| Listed, but not rankable — no published strength to price per mg | |||||||
| — | PurerawzUnavailable | 1 vial | $61 | no size published | — | — | View |
| — | PurerawzUnavailable | Nasal Spray · 100mcg per spray/10ml/10mg | $358 | no size published | — | — | View |
| — | Purerawz | Nasal Spray · 200mcg per spray/10ml/20mg | $573 | no size published | — | — | View |
Open the full Tirzepatide market
Real $/active mg divides the price-per-mg by the measured purity — the honest cost of the actual peptide, so a 90%-pure vial isn’t compared as if it were 99%. Too cheap? flags a listing far below the market rate — often underdosing or a fake, not a deal. The crown marks the cheapest non-outlier; best value marks the lowest real cost per active mg. A vendor shown as Unavailable or Low stock is priced here but not currently buyable.
Independent testing
Tirzepatide — independent lab tests
Real, publicly verifiable third-party tests. Purity is read from the certificate itself. A test reflects one lab’s result for one submitted batch — not a guarantee that every vial matches.
How does this data get here?
Every record below is a real certificate of analysis, gathered two ways: from the public verification feeds that independent labs (like Janoshik) publish, and from the certificates vendors post on their own product pages. We open each certificate document and read the measured purity, content, batch, and date directly off it — a scraper can’t read a number printed inside an image, so this is done by machine vision, then recorded here with a link back to the original.
Nothing here is typed in by a vendor or invented by us. Where a certificate is missing, we say so rather than filling the gap.
We re-check the lab feed, too. A “still listed” tag means the certificate is currently public in Janoshik’s database — we re-verify against the live feed and stamp the date. If a cert is later pulled, the tag flips. It’s a freshness check on the same source, not a second independent opinion.
What a certificate does & doesn’t prove
Three different questions. Purity (“how clean?”), identity (“is it the right molecule?”, a mass-spec test), and content (“did I get the labeled mg?”) are separate. A vial can be 99% pure and still be the wrong peptide, or the right peptide underdosed. We flag the measured dose against the label above; underdosing is the most common real fraud.
Who submitted the sample matters. Most of these are vendor-submitted — the seller chose which vial to send, so one good certificate doesn’t prove every batch is the same. The gold standard is a blind test, where a buyer sends a vial they bought as a normal customer. Same label doesn’t prove same product; same batch number doesn’t prove same batch.
20
blind tests
99.9%
highest tested purity
| Certificate | Manufacturer | Batch | Purity | Content / dose | Lab | |
|---|---|---|---|---|---|---|
| www.optimumsourceresearch.com Blind | T-031026-01 | 99.89% | 24.54/20mg · | Janoshik Analytical Still listed | Verify | |
| www.ssrbio.com Blind | 2026 | 99.89% | 33.67/30mg · full | Janoshik Analytical Still listed | Verify | |
| https://www.rayshine-peptide.com/ Blind | RSP20260315 | 99.85% | 32.74/30mg · full | Janoshik Analytical Still listed | Verify | |
| liliPetide Technology Co., Ltd. Blind | — | 99.84% | 35.58/30mg · full | Janoshik Analytical Still listed | Verify | |
| http://www.sahepeptides.com/ Blind | — | 99.81% | 34.73/30mg · full | Janoshik Analytical Still listed | Verify | |
| https://www.htraresearch.cn Blind | — | 99.75% | 21.79/20mg · full | Janoshik Analytical Still listed | Verify | |
| www.uwa-biotech.com Blind | blue | 99.69% | 45.42/40mg · full | Janoshik Analytical Still listed | Verify | |
| Whatsapp:①+852-56419109 ②+44 7467 123605 Blind | June 12, 2026 | 99.69% | 31.96/30mg · full | Janoshik Analytical Still listed | Verify | |
| Kangpeptide Technology Co., Ltd Blind | — | 99.69% | 17.37/15mg · full | Janoshik Analytical Still listed | Verify | |
| www.jianxilab.com Blind | — | 99.67% | 10.31/10mg · full | Janoshik Analytical Still listed | Verify | |
| peptidesfactorycn.com Blind | 4 | 99.64% | 22.81/20mg · full | Janoshik Analytical Still listed | Verify | |
| www.certapeptides.com Blind | CP-2605-TR10 | 99.60% | 11.24/10mg · full | Janoshik Analytical Still listed | Verify | |
| https://www.hhmpeptide.com/ Blind | — | 99.51% | 22.53/20mg · full | Janoshik Analytical Still listed | Verify | |
| www.certapeptides.com Blind | CP-2604-TIR5 | 99.50% | 5.48/5mg · full | Janoshik Analytical Still listed | Verify | |
| hangzhoupeps.com Blind | — | 99.03% | 11.14/10mg · full | Janoshik Analytical Still listed | Verify | |
| peponte.com Blind | — | See report | — | Janoshik Analytical | Verify | |
| verpep.com Blind | — | See report | — | Janoshik Analytical | Verify | |
| pepvor.com Blind | — | See report | — | Janoshik Analytical | Verify | |
| zypep.com Blind | — | See report | — | Janoshik Analytical | Verify | |
| apeptix.com Blind | — | See report | — | Janoshik Analytical | Verify | |
Tested batches
Batch test records for Tirzepatide
The full test history for one batch — who picked the sample, who tested it, and what came back. It describes the vials that were tested, never every vial they sold.
What the research says
Scientific evidence & regulatory status
What the published literature actually shows about Tirzepatide — separate from any vendor’s marketing. Each finding links to its paper. This is education, not medical or dosing advice.
Regulatory status
An approved drug exists — this is not it
FDA-approved as Mounjaro for type 2 diabetes (NDA 215866) and Zepbound for chronic weight management (NDA 217806), both prescription-only. Research-grade tirzepatide sold online is not that product, and the FDA has warned specifically about unapproved GLP-1 drugs sold for weight loss.
Honest overall read
High-quality human RCT evidence shows tirzepatide (a dual GIP/GLP-1 agonist) yields among the largest weight losses of any approved agent; GI side effects are common but usually manageable, and long-term cardiovascular-outcome data are still maturing.
In the 72-week SURMOUNT-1 RCT of 2,539 adults with obesity (without diabetes), once-weekly tirzepatide produced least-squares mean weight reductions of -15.0%, -19.5%, and -20.9% at the 5, 10, and 15 mg doses versus -3.1% with placebo.
GI adverse events (nausea, diarrhea, constipation) were most common, mostly mild-to-moderate and concentrated during dose escalation.
read the sourceReference source
Tirzepatide is the active ingredient in FDA-approved medicines made by Eli Lilly (Mounjaro, Zepbound). Grey-market “Tirzepatide” sold for research is not Eli Lilly’s product and is not the FDA-approved drug — a different, unregulated supply chain under the same chemical name. See what pharmaceutical-grade means →
This is a prescription drug in the US
This is the active drug in Mounjaro and Zepbound — an FDA-approved prescription medication. Buying a “research” version sidesteps the prescription requirement and the approved, quality-controlled supply chain. The FDA has warned about and acted against unapproved and compounded copies. Higher legal and safety exposure than an unapproved research peptide.
General information, not legal or medical advice. VialGrade sells nothing and encourages no human use.
Research notes aren’t product proof
Research summaries describe published literature and market data only. They do not establish the identity, quality, safety, or legal status of any listed physical product.